Joshua Richter, MD from John Theurer Cancer Center discusses inclusion and exclusion criteria of GBR 1342 and the trial designed for patients who have no proven therapy available at the 2017 American Society of Hematology.
Inclusion and Exclusion Criteria of GBR 1342 – Trial designed for patients who have no proven therapy available
